Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voice analysis changes after autologous bone marrow mononuclear cell transplantation
jRCT1030260430Recruiting
- Start
- Sep 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in Dementia, brain infarction and amyotrophic lateral sclerosis (ALS), sponsored by none. Started Sep 2026; status: recruiting.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Dementiabrain infarctionamyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on jRCT1030260430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260430.